Clinical trial
Gender-dependent Symptoms Following Anti-COVID-19 Vaccine in a Lebanese and Italian Populations
NCT05735769 is registered in ClinicalTrials.gov with University of Bari as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gender-dependent Symptoms Following Anti-COVID-19 Vaccine in a Lebanese and Italian Populations
- Lead sponsor
- University of Bari
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2021
- Completion date
- September 15, 2021
- Enrollment
- 2,797 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 vaccine adverse reaction, gender, vaccine adverse reaction